Clinical Trial Update: A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study investigated the absolute bioavailability of insulin degludec in healthy subjects to characterize pharmacokinetic properties.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Tresiba (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED